Literature DB >> 24381423

Hyperhomocysteinemia, as an independent risk factor for retinal venous occlusion in an Indian population.

Kapil D Lahiri1, Jayanta Dutta2, Himadri Datta2, Harendra N Das3.   

Abstract

Total plasma homocysteine was analysed in 64 cases of retinal vein occlusion (RVO) of which 24 cases of central retinal vein occlusion (CRVO) and 40 cases of branch retinal vein occlusion (BRVO) and compared with 45 age and sex matched control. Homocysteine was significantly increased in RVO cases in respect to control (P < 0.001). Analysis also revealed that prevalence of rise of plasma homocysteine was more in cases of CRVO (OR = 13) than that of BRVO (OR = 5.03).

Entities:  

Keywords:  Branch retinal vein occlusion (BRVO); Central retinal vein occlusion (CRVO); Homocysteine (Hcys); Hyperhomocysteinemia (HHcys); Odds ratio (OR); Retinal vein occlusion (RVO)

Year:  2012        PMID： 24381423      PMCID： PMC3547439          DOI： 10.1007/s12291-012-0238-3

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN： 0970-1915


  27 in total

1.  Homocysteine and retinal emboli: the Blue Mountains Eye Study.

Authors:  Brian Chua; Annette Kifley; Tien Y Wong; Paul Mitchell
Journal:  Am J Ophthalmol       Date:  2006-08       Impact factor: 5.258

Review 2.  Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.

Authors:  N Weiss
Journal:  Curr Drug Metab       Date:  2005-02       Impact factor: 3.731

Review 3.  Total homocysteine in plasma or serum: methods and clinical applications.

Authors:  P M Ueland; H Refsum; S P Stabler; M R Malinow; A Andersson; R H Allen
Journal:  Clin Chem       Date:  1993-09       Impact factor: 8.327

4.  Disturbed visual system function in methionine synthase deficiency.

Authors:  Charlotte M Poloschek; Brian Fowler; Renate Unsold; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-18       Impact factor: 3.117

Review 5.  Molecular targeting by homocysteine: a mechanism for vascular pathogenesis.

Authors:  Donald W Jacobsen; Otilia Catanescu; Patricia M Dibello; John C Barbato
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

Review 6.  The many facets of hyperhomocysteinemia: studies from the Framingham cohorts.

Authors:  Jacob Selhub
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

7.  Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone.

Authors:  Mohsen Kerkeni; Mehdi Tnani; Laurence Chuniaud; Abdelhedi Miled; Khira Maaroufi; François Trivin
Journal:  Mol Cell Biochem       Date:  2006-05-19       Impact factor: 3.396

8.  Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.

Authors:  Wei Gao; Yu-Sheng Wang; Peng Zhang; Hai-Yan Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

9.  Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.

Authors:  Lorenzo Di Crecchio; Maurizio Battaglia Parodi; Giorgia Sanguinetti; Pierluigi Iacono; Giuseppe Ravalico
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

10.  Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.

Authors:  Mark T Cahill; Sandra S Stinnett; Sharon Fekrat
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258
View more
  6 in total

1.  Retino-choroidal ischemia in central retinal vein occlusion.

Authors:  Nazimul Hussain; Anjli Hussain
Journal:  Saudi J Ophthalmol       Date:  2014-02-25

2.  Association of homocysteine with type 1 diabetes mellitus: a meta-analysis.

Authors:  Yu Feng; Mei-Qin Shan; Lin Bo; Xiao-Yan Zhang; Ji Hu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase.

Authors:  Kapil Deb Lahiri; Somnath Mukherjee; Sambuddha Ghosh; Suman Mukherjee; Jayanta Dutta; Himadri Datta; Harendra Nath Das
Journal:  Korean J Ophthalmol       Date:  2015-03-17

Review 4.  Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.

Authors:  Dan Li; Minwen Zhou; Xiaoyan Peng; Huiyu Sun
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

5.  Role of hyperhomocysteinemia and Vitamin B12 deficiency in central and hemi-central retinal vein occlusion: A case-control study.

Authors:  Dhipak Arthur; Deepa John; Jude Joseph Fleming; Grace Rebekah; Mahasampath Gowri; Sheeja Susan John
Journal:  Oman J Ophthalmol       Date:  2022-03-02

6.  Cystoid Macular Edema Associated With Venous Stasis in a Patient With Previously Undiagnosed Hyperhomocysteinemia.

Authors:  Stergios K Chaloulis; Konstantinos T Tsaousis
Journal:  Cureus       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.